Cellumed KRX:049180KOSDAQ
셀루메드 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Cellumed reported revenue of ₩30.8bn, down 12.9% year on year, and operating profit of ₩1.6bn. Cellumed (셀루메드) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Turnaround Screener
Cellumed quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩30.8bn | -12.9% | ₩1.6bn margin 5.1% | ₩2.6bn |
| Q1 2026 | ₩23.4bn | -40.3% | −₩1.6bn margin −6.7% | −₩1.7bn |
| Q4 2025 derived | ₩28.3bn | -22.8% | −₩649m margin −2.3% | −₩6.3bn |
| Q3 2025 | ₩37.3bn | +12.0% | ₩1.4bn margin 3.9% | ₩8.0bn |
| Q2 2025 | ₩35.4bn | +7.3% | −₩4.3bn margin −12.2% | −₩2.5bn |
| Q1 2025 | ₩39.2bn | +49.4% | −₩1.6bn margin −4.1% | −₩1.4bn |
| Q4 2024 derived | ₩36.6bn | +35.0% | −₩3.4bn margin −9.4% | −₩25.5bn |
| Q3 2024 | ₩33.3bn | +30.5% | −₩1.2bn margin −3.7% | −₩1.9bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Cellumed top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Cellumed news Korean headlines
No articles yet.